England Launches Innovative Medicines Fund
Executive Summary
The new financing mechanism promises faster access to new treatments, but some industry concerns remain unresolved.
You may also be interested in...
England’s Unused Innovative Medicines Fund Under Fire Again
A group of UK academics have broadly welcomed the fund that will pay for innovative non-cancer drugs, but have expressed concern over issues such as the entry criteria and the definition of “high unmet need.” They also say safeguards are needed against possible financial loss to the National Health Service.
England’s Innovative Medicines Fund: Opportunities & Risks
England’s Innovative Medicines Fund could make the UK a more attractive launch market following Brexit, but companies must also consider the risks of the fund.
England: HTA Body NICE Makes Big RWE Push
England’s health technology appraisal institute, NICE, has published its real-world evidence framework.